Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LALPATHLAB | BSE
-50.15
-1.83%
Healthcare
Diagnostics & Research
30/09/2023
04/12/2023
2,689.90
2,734.05
2,758.40
2,686.10
Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry hematology histopathology microbiology electrophoresis immuno-chemistry immunology virology cytology and other pathological and radiological investigations. The company also offers lab staff training; technical; and lab management services. As of March 31 2022 the company had 277 clinical laboratories including National Reference Lab at Delhi and Regional Reference Lab at Kolkata; and 4731 patient service centers and 10599 pick-up points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurugram India.
View LessPositive Momentum
Low 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Midcap (2B - 10B USD)
Weak P/E, and PEG ratio indicator
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
28.3%1 month
26.3%3 months
28.8%6 months
28.7%75.75
66.23
12.52
0.17
0.12
35.35
10.16
0
5.04B
223.87B
2.68B
0.66
23.60
52.60
12.60
17.99
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
164.75
Range1M
181.80
Range3M
600.60
Rel. volume
0.84
Price X volume
17.26M